Wombat Capital

Wombat Capital is a cross-border investment banking and strategic advisory firm based in New York. Founded in 2009, the firm employs four individuals and generates over $10,000 in annual revenue. Wombat Capital specializes in serving entrepreneurs, board of directors, financial investors, and private and public companies across various sectors. The company provides a comprehensive suite of advisory services tailored to the lower middle market. These services encompass mergers and acquisitions (both buy-side and sell-side), debt and equity financing, valuation and fairness opinions, joint ventures, and strategic alliances. Wombat Capital's industry focus centers on life sciences and healthcare, with expertise spanning pharmaceutical, biotech, contract services and outsourcing, diagnostics, medical devices, and healthcare IT. Wombat Capital distinguishes itself through its in-depth understanding of a company's unique challenges, opportunities, and drivers for success. By leveraging the industry sector expertise of its bankers, the firm aims to secure the optimal value and outcome for its clients and their shareholders. Wombat Capital Markets LLC, the firm's registered broker-dealer subsidiary, is a member of FINRA (www.finra.org) and SIPC (www.sipc.org). Interested parties can learn more about Wombat Capital and its professionals through FINRA Brokercheck (brokercheck.finra.org) or by visiting the company's website at www.wombatcapital.com.